INS and diabetic ketoacidosis: Three studies also shared revised treatment practices that their facilities had implemented to reduce COVID-19 exposure risk, such as care for patients with diabetic ketoacidosis using subcutaneous insulin every 4 hours, rather than via an insulin infusion pump, to reduce bedside time, risk of staff exposure, and requirement for personal protective equipment.